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Activation of the ATPase Activity of Hsp90
by the Stress-Regulated Cochaperone Aha1
eukaryotic cells (Pearl and Prodromou, 2002). Rather
than acting at an early stage of folding, Hsp90 binds
client proteins in a substantially folded form and facili-
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ResultsClient protein activation by Hsp90 involves a plethora
of cochaperones whose roles are poorly defined. A
Identification of the Hch1/Aha1-Protein Familyubiquitous family of stress-regulated proteins have
Homology searches with HCH1 (153 amino acids), abeen identified (Aha1, activator of Hsp90 ATPase) that
high-copy-number suppresser of a Hsp90 ts-mutationbind directly to Hsp90 and are required for the in vivo
(E381K) (Nathan et al., 1999), revealed the yeast openHsp90-dependent activation of clients such as v-Src,
reading frame (ORF), YDR214W (designated AHA1).implicating them as cochaperones of the Hsp90 sys-
AHA1 encoded a hypothetical 350 residue proteintem. In vitro, Aha1 and its shorter homolog, Hch1,
whose N-terminal half had 36.5% sequence identity tostimulate the inherent ATPase activity of yeast and
Hch1 but with an additional 197 residues at the C termi-human Hsp90. The identification of these Hsp90 co-
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over its entire length could be identified in organismscochaperones in regulating the ATPase-coupled con-
from yeast to humans. Only one other example of theformational changes of the Hsp90 chaperone cycle.
shorter Hch1-like sequence was identified in the yeast
C. albicans (Figure 1A). Two genes encoding clear ho-Introduction
mologs of Aha1 were identifiable in the draft human
genome, one mapping to chromosome 2 (Ensembl geneHsp90 is an essential cellular chaperone, involved in the
activation of key signaling and regulatory systems in 00000152645) and the other to chromosome 14 (En-
sembl gene 00000100591, now designated hAha1).
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Figure 1. Domain Structure and Expression
Profiles of Aha1 and Hch1
(A) Homologs of the 350 residue S. cerevisiae
Aha1 protein (Sc-Aha1) were identified in A.
thaliana, D. melanogaster, C. elegans, H. sa-
piens (chromosome 14, Ensembl gene
00000100591), and S. pombe, while a homo-
log of the shorter 153 residue Hch1 protein
was only identified in C. albicans. Sequence
identity among Aha1 homologs varies be-
tween 19.7%–38.3%. The Hch1 protein and
N-terminal domain of Aha1 have 36.5% se-
quence identity.
(B) Expression profiles for S. cerevisiae
Hsp90 (HSP82) and the known cochaperones
CPR6 and STI1 match closely those of AHA1
and HCH1 while those of Hsp90 client pro-
teins (e.g., GCN2 and CDC28) are very differ-
ent. Each vertical bar represents a different
stress condition, with bars above the center
line representing upregulation, those below
representing downregulation, and the length
of the bar reflecting the degree of change
in expression. This figure was adapted from
Gasch et al. (2000), and the exact conditions
of stress can be found in that publication.
expressed in most tissues. Database searches using Hsp90 inhibitor, increased expression of several heat
shock and stress-regulated genes, including Hsp70sPSI-BLAST failed to identify any distant homologs of
known function, and sequence threading failed to iden- and Hsp90 (Clarke et al., 2000). In contrast, levels of
CPs, such as Raf-1 and Akt/PKB, decrease (Hostein ettify any known protein fold within Aha1/Hch1 se-
quences, from which their function might be inferred. al., 2001). Expression array analysis of hAha1 shows
clear upregulation in response to 17AAG treatment or
heat shock, as observed for other chaperones/cochap-Stress Regulation of HCH1, and AHA1
and Its Human Homolog erones (Figures 2A and 2B). In support of this, anti-yeast
Aha1 polyclonal serum crossreacted with a band of theIts original isolation as a suppresser of an Hsp90 ts-
mutation (Nathan et al., 1999) raised the possibility that correct relative molecular weight whose intensity in-
creases following 17AAG or heat shock treatment ofHCH1, and consequently AHA1, might encode pre-
viously uncharacterized cochaperones of the Hsp90 HT29 cells (Figure 2C). Subsequently, an upregulated
protein identified in 2D gels of 17AAG-treated A2780complex. This notion is supported by the behavior of
HCH1 AHA1 genes in response to various stress condi- cells (Figure 2D) was identified as hAha1 by MALDI-MS
peptide mass mapping. Increased levels of the Aha1-tions (Gasch et al., 2000). Both genes display patterns
very similar to HSP82 and cochaperones such as STI1 homolog was fully consistent with the behavior of known
chaperones/cochaperones (Clarke et al., 2000) and sug-and CPR6 but quite different from the Hsp90 clients,
GCN2 and CDC28 (Figure 1B). Consistent with their pat- gest that, like its yeast counterpart, at least one human
Aha1 homolog is also subject to stress regulation.terns of stress regulation, AHA1 and HCH1 promoters
contain consensus heat shock-factor elements (HCH1:
165 to 157, TTCTAGAA; AHA1: 363 to 356, GAA Dependence of Cell Growth and Client Protein
Activation on Aha1 and Hch1TATTC; 301 to 294, GAATTTTC; and 105 to 98,
GAAAGTT). We have previously shown that treatment If Aha1 and Hch1 are cochaperones of the Hsp90 sys-
tem, then deficiencies in these might affect the functionof mammalian cells with the geldanamycin (GA) derivative
17-allylamino, 17-demethoxygeldanamycin (17AAG), an of the Hsp90 system in yeast. To test this, we con-
Hsp90 ATPase Activators
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Figure 2. Microarray and Proteomic Analysis of Human Aha1 Expression
(A) Scatter plot of control gene expression versus 17AAG treated (60 nM) in A2780 cells. Each point is a single gene; a 1:1 ratio is expected
if expression is unchanged by treatment (central line). Outer dotted lines mark a 2-fold change in expression. The full microarray profile is
available as supplemental data at http://www.molecule.org/cgi/content/full/10/6/1307/DC1.
(B) Changes of gene expression in human colorectal (HCT116, HCT15, and HT29) and ovarian (A2780) cancer cells treated for 24 hr with
Hsp90 inhibitors (60 nM 17AAG or 0.6 M radicicol) or heat shock (HS). Red indicates increase by treatment; green, a decrease; black, no
change; and gray, a missing value. hAha1 expression increases strongly following heat shock and to a lesser extent with 17AAG or radicicol
treatment.
(C) Western blot of HT29 cells treated with either 17AAG (50 nM) or heat shock (HS). C, untreated cells. A band corresponding in size to the
expected hAha1 and crossreacting with anti-yAha1 Abs is detected (indicated by the arrow) and is seen to increase with 17AAG and HS
treatment. Similarly, Hsp70 expression increases with 17AAG and HS treatment as previously observed (Clarke et al., 2000). GADPH is the
loading control.
(D) Two-dimensional gels showing induction of hAha1 protein (indicated by the arrow) in A2780 control cells and after 8, 16, and 24 hr of
17AAG treatment. Results show that hAha1 is induced following treatment. Paired gels were run for each time point, with four gels at time 0.
The mean relative intensities at each time point with respect to time 0 were 1.2 at 8 hr, 1.8 at 16 hr, and 2.0 at 24 hr. The Mr and PI of Aha1
estimated from the gel were 41 and 5.44 kDa, respectively. MALDI mass spectrometry following tryptic in-gel digests of the upregulated spot
identified fourteen species matching tryptic peptides of hAha1. Sequence coverage was 55%, and all peptides matched the DNA-derived
hAha1 sequence.
structed strains deleted for AHA1 (aha1), HCH1 three strains were viable, indicating that Aha1 and Hch1
are not essential components of the Hsp90 system.(hch1), or both (aha1-hch1) and analyzed their
growth characteristics. Under normal conditions all However, aha1 and the double-delete strain displayed
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Figure 3. Stress Resistance and v-Src Acti-
vation of AHA1- and HCH1-Deficient Strains
(A) Cells grown on YPDA (30C  30 hr) after
being subjected to a temperature gradient of
34C–39C for 40 hr. aha1 and aha1-hch1
strains are marginally temperature sensi-
tive (ts).
(B) Cells grown on respiratory medium
(YPEG, 30C) after being subjected to a tem-
perature gradient of 30C–39C for 40 hr. Un-
der conditions of increased stress the ts-
growth phenotype is more marked, with the
double-deleted strain showing a more severe
impairment.
(C) Western blot showing protein phosphoty-
rosine levels in yeast cell extracts following
induction of v-Src expression on galactose
(G) rather than raffinose (R) medium. Activa-
tion of v-Src is compromised in theaha1 and
more severely in aha1-hch1 backgrounds,
indicated by lower levels of phosphotyrosine
incorporation. The more severe phenotype of
the double mutant suggests that Hch1 can to
a limited degree restore loss of Aha1 function
(see text). Levels of accumulated v-Src are
lower in the aha1 background and almost
undetectable in the double delete, consistent
with rapid degradation of expressed v-Src
when the Hsp90 system is compromised.
growth sensitivity at elevated temperatures (Figure 3A), that is required in v-Src activation but can be replaced
to some degree by Hch1. The level of accumulated v-Srca phenotype that was enhanced and also shown by
the hch1 strain, during increased stress by growth on protein immediately following induction was lower in the
aha1 strain than in wild-type and nearly undetectablerespiratory medium (Figure 3B).
To determine whether Aha1 and Hch1 are directly in the double delete (Figure 3C). The very low levels of
v-Src is not due to loss of expression since cells fail toinvolved in the activation of CPs in vivo, the v-src onco-
gene, encoding a protein tyrosine kinase under the regu- grow on galactose in common with the wild-type and
aha1, hch1 strains. Rather it reflects the destabiliza-lation of a galactose promoter, was transformed into S.
cerevisiae FY 1679-28C and into the aha1, hch1, and tion and rapid degradation of unactivated v-Src protein
when the Hsp90 system is compromised, as has beenaha1-hch1 mutant strains. Activation of v-Src is
strongly dependent on functional interaction with the previously observed (Nathan et al., 1999). These results
indicate that under the growth conditions used, Aha1Hsp90 system in mammalian and avian cells and re-
mains so when expressed in yeast, where its expression and, to a lesser extent, Hch1 are directly involved in
Hsp90-dependent v-Src activation.is toxic. In all cases, cells were viable on glucose but
failed to grow on galactose, indicating that expression
of the v-src gene was indeed induced on galactose me- Hch1 and Aha1 Are Hsp90 Binding Proteins
As the genetic data suggest that Aha1 and/or Hch1dium and that sufficient active v-Src protein was made
to produce toxicity in all the strains (wild-type, aha1, are involved in CP activation, we sought to determine
whether Aha1 and Hch1 interact with Hsp90 in vivo,hch1, andaha1-hch; data not shown). To investigate
the more subtle effects of Aha1 and Hch1 on the activa- using a selective yeast two-hybrid assay. Neither Aha1
nor Hch1 interacted with themselves or with each othertion of v-Src, the cellular phosphotyrosine profile was
analyzed immediately after transfer from raffinose to sufficiently strongly to sustain cell growth, even at the
lowest level of selection. However, both proteins inter-galactose medium. Tyrosine phosphorylation of yeast
proteins by v-Src was compromised when the AHA1 acted with Hsp90, with Aha1 able to sustain growth
at higher levels of selection (Figure 4A). Furthermore,gene was deleted and especially so in the double delete
aha1-hch1 background (Figure 3C). This suggests purified Aha1 incubated with a bacterial lysate con-
taining Flag-tagged Hsp90 could be efficiently immuno-that under these growth conditions it is primarily Aha1
Hsp90 ATPase Activators
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Figure 4. Hch1 and Aha1 Interactions with Hsp90
(A) Growth of colonies in the selective yeast two-hybrid assay indicates interaction between the proteins attached to the DNA binding domain
(BD) and transcriptional activation domain (AD) in vivo. Both Aha1 and Hch1 interact with Hsp90 in this assay.
(B) Coimmunoprecipitation (IP) of Flag-tagged Hsp90 and His6-tagged Aha1 with anti-Flag Ab linked to agarose beads, detected using anti-
His6 Ab. Lane 1, IP of Aha1 without Flag-tagged Hsp90; lane 2, co-IP of Aha1 and Flag-tagged Hsp90. Aha1 co-IPs only in the presence of
Flag-tagged Hsp90. Note that the anti-mouse secondary Ab, detecting the primary anti-His6 Ab, also recognizes the anti-Flag Ab.
(C) Near-UV CD spectra for titration of Hch1 into Hsp90. (a) Hsp90 alone (4.84 M); (b–e) Hsp90/Hch1 mixtures in the molar ratios of 1:n
(n  0.3, 0.6, 1.0, and 1.5). The KD was estimated using a Levenberg-Marquardt fit from the binding curve as 1.9  1.1 M. Saturation of
binding was at 1:1.1 (Hsp90:Hch1) indicating that the stoichiometry of the interaction is 1:1.
(D) As in (C) but titration of Aha1 into Hsp90. (a) Hsp90 (2.42 M) alone; (b–e) Hsp90/Aha1 mixtures in the molar ratios of 1:n (n  0.48, 1.05,
2.07, and 3.16). The KD estimated using a Levenberg-Marquardt fit for the interaction was 0.33  0.1 M, and for Aha1 and Hsp90-AMPPNP
it was 0.2 M (data not shown). Saturation of binding was at 1:1.1 (Hsp90:Aha1) indicating that the stoichiometry of the interaction is 1:1.
precipitated using immobilized anti-Flag Ab, indicating affinity of Aha1 and Hch1 for Hsp90 was determined
using difference circular dichroism (CD) (see Experi-that the interaction of Hsp90 with Aha1 (and by implica-
tion Hch1) observed in vivo was direct (Figure 4B). The mental Procedures). Dissociation constants estimated
Molecular Cell
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Figure 5. Aha1 Activation of the ATPase Ac-
tivity of Hsp90 Proteins
(A) Activation of Hsp90 ATPase (2 M) by
Aha1. The amount of Aha1 required for half
maximal activation is1.4 M indicating that
a 1:1 stoichiometric complex is formed.
(B) The effect of nAha1 () and Hch1 () on
the ATPase activity of yeast Hsp90. cAha1
() has no effect.
(C) Estimation of the KM for the ATPase activ-
ity of Hsp90 ( and right-hand scale) and the
Hsp90-Aha1 complex ( and left-hand scale).
The presence of Aha1 does not significantly
alter the KM of the reaction (indicated by
arrows).
(D) Activation of human Hsp90 (20 M) by
Aha1 and inhibition by GA.
from the fitted binding curves were 1.9 (1.1) M (Hch1) tent with the CD data. Hch1 and the Hch1-homologous
N-terminal region of Aha1 (nAha1) also stimulated Hsp90and 0.33 (0.1)M (Aha1) with1:1 (Hsp90:Aha1/Hch1)
stoichiometry in both cases (Figures 4C and 4D). ATPase but only to30% of that achieved by full-length
Aha1 (Figure 7B). The C-terminal region of Aha1 in isola-
tion produced no ATPase stimulation at up to a 32 molarAha1 and Hch1 Are Activators of Hsp90’s
excess over Hsp90. The stimulated ATPase activitiesATPase Activity
were fully sensitive to inhibition by the specific Hsp90The biological activity of Hsp90 depends on its ability
ATPase-inhibitor GA, confirming that it was due to hy-to bind and hydrolyze ATP (Panaretou et al., 1998; Ober-
drolysis of ATP by Hsp90, and not by Aha1 or Hch1,mann et al., 1998), and we have previously shown that
which have no measurable ATPase activity of their own.this activity is downregulated by the cochaperones Sti1/
The near-UV CD-spectrum of isolated Aha1 was unper-Hop and Cdc37p/p50cdc37 but largely unaffected by oth-
turbed by the addition of GA, ADP, or AMP-PNP (dataers (Prodromou et al., 1999; Siligardi et al., 2002). As
not shown) indicating that in isolation Aha1 binds neitherAha1 and Hch1 clearly interact with Hsp90, we sought
nucleotides nor GA. Similarly, the spectrum of Hch1 wasto determine their effect on the ATPase activity. In initial
unperturbed by the addition of AMP-PNP. To test thestudies we found that binding of Aha1 and Hch1 to
possibility that Aha1 may possess a cryptic ATPaseHsp90 was salt sensitive and a lower-salt buffer was
activity only manifest when associated with cyclingused than in previous studies (see Experimental Proce-
Hsp90, we also determined the effect of saturating levelsdures). In these assays, Aha1 proved to be a potent
of Aha1 on the KD for AMPPNP binding by Hsp90 andactivator (Figure 5A), stimulating the ATPase activity of
on the KM for the Hsp90 ATPase reaction. The measuredyeast Hsp90 to12 times its basal level. Approximately
KD of 50 M (data not shown) compares with previous1.4 M of Aha1 was required to achieve half maximal
estimates of 33 M (Prodromou et al., 2000), and theactivation with 2M Hsp90 present in the assay, indicat-
ing that a 1:1 stoichiometric complex is formed, consis- KM measurements showed no significant differences
Hsp90 ATPase Activators
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(Figure 5C). It is reasonable to conclude that the acti-
vated ATPase is provided entirely by Hsp90, and results
from an increase in Kcat produced by binding of Aha1.
In contrast to the yeast protein, the human -isoform
of Hsp90 displays only a very low level of inherent
ATPase activity under similar assay conditions. How-
ever, addition of Aha1 increased its ATPase activity to
readily measurable levels (Figure 5D). In light of its ability
to activate the ATPase of Hsp90, we have designated
the YDR214W ORF as AHA1 (activator of Hsp90 ATPase
activity).
Aha1 Coexists with Early and Late Hsp90
Cochaperone Complexes
CP activation by Hsp90 proceeds via a series of defined
stages characterized in part by the cochaperones pres-
ent in the Hsp90-CP complex (Smith, 2000). Early com-
plexes are devoid of ATP and contain Sti1/Hop or
Cdc37/p50cdc37, which are replaced in later complexes
by TPR domain immunophilins such as Cpr6/Cyp40 and
FKBP52. Furthermore, the binding of these cochaper-
ones to Hsp90 is mutually exclusive (Owens-Grillo et al.,
1996; Silverstein et al., 1998). Sba1/p23 only binds to
Hsp90 in the presence of ATP (Fang et al., 1998; Johnson
and Toft, 1995) and can coexist with Cpr6 but not Sti1/
Hop. Using CD, we analyzed the nature of the com-
plexes that could be formed with Hsp90 by Aha1. Mix-
tures of Aha1, cSti1, and Hsp90 gave a CD spectrum
most consistent with simultaneous binding of Aha1 and
cSti1 to Hsp90 (Figure 6A). Similarly, addition of Sba1
and Aha1 to AMPPNP-saturated Hsp90 gave a spectrum
consistent with both cochaperones bound simultaneously
(Figure 6B). Addition of Cpr6 to this putative Aha1-
Hsp90-AMPPNP-Sba1 complex elicited a further spectral
change that was not observed when Aha1 was absent
from the mixture, suggesting that the interaction of Cpr6
Figure 6. Near-UV Difference-CD Spectra Showing Protein Interac- with Hsp90 is altered in the presence of Aha1 (Figure 6C).
tions between Aha1, Hsp90, and Hsp90 Cochaperones
Observed spectra for multicomponent mixtures are compared with Cochaperone Modulation of Aha1-Stimulated Hsp90
calculated spectra for different theoretical complexes, calculated ATPase Activityby linear combination of the spectra for the separate components
We have previously shown that the inherent ATPasein the same molar ratio as present in the actual mixture.
activity of Hsp90 is inhibited by Sti1/Hop and Cdc37p/(A) Near-UV CD for mixtures of Hsp90, Aha1, and cSti1. (a) Ob-
served spectrum for the mixture of Hsp90 (49.6 M), Aha1 (49.6 p50cdc37, while the TPR-domain immunophilins, such as
M), and cSti1 (49.6 M); (b) calculated spectrum for an Aha1- Cpr6, have no significant direct effect on the ATPase
Hsp90-cSti1 complex; (c) calculated spectrum for an Aha1-Hsp90 but reactivate it by competitive displacement of Sti1/
complex and unbound cSti1; (d) calculated spectrum of an Hsp90- Hop or Cdc37p/p50cdc37 (Prodromou et al., 1999; SiligardicSti1 complex and unbound Aha1; and (e) calculated spectrum of
et al., 2002). More recently, we have found that p23/Hsp90, unbound Aha1, and unbound cSti1. The observed (a) and
calculated spectrum of the Aha1-Hsp90-cSti1 complex (b) are es-
sentially identical, indicating that an Aha1-Hsp90-cSti1 complex is
formed.
(B) Near-UV CD for mixtures of Hsp90-AMPPNP, Aha1, and Sba1. plex (proteins at 48.82 M and AMPPNP at 97.64 M) results in
(a) Observed spectrum for the mixture of Hsp90-AMPPNP (48.82 changes in the near-UV CD spectrum that are not observed when
M and 97.64 M, respectively), Aha1 (48.82 M), and Sba1 (48.82 the complex lacks Aha1. Spectra were calculated by subtracting
M); (b) calculated spectrum for an Aha1-Hsp90-AMPPNP-Sba1 the observed spectrum for the complex of the components other
complex; (c) calculated spectrum for an Aha1-Hsp90-AMPPNP than Cpr6 from the observed spectrum for that complex with the
complex and unbound Sba1; (d) calculated spectrum of an Hsp90- addition of Cpr6. (a) Observed spectrum of free Cpr6; (b) calculated
AMPPNP-Sba1 complex and unbound Aha1; and (e) calculated spectrum of Cpr6 in the presence of Hsp90-AMPPNP complex; (c)
spectrum of Hsp90-AMPPNP, unbound Aha1, and unbound cSti1. calculated spectrum of Cpr6 with AMPPNP, Aha1, and Sba1; and (d)
The observed (a) and calculated spectrum of the Aha1-Hsp90- calculated spectrum of Cpr6 in the presence of an Hsp90-AMPPNP-
AMPPNP-Sba1 complex (b) are essentially identical, indicating that an Aha1-Sba1 complex. In all cases the recalculated spectrum for Cpr6
Aha1-Hsp90-AMPPNP-Sba1 complex is formed. Furthermore, (f) the matched the observed spectrum for Cpr6 alone except when Aha1
near-UV CD spectrum of an Aha1-Hsp90-AMPPNP-Sba1 complex un- was present in an Hsp90 complex, suggesting that structural
dergoes further structural changes following the addition of Cpr6. changes occur within the Hsp90 complex when Aha1 and Cpr6 are
(C) Addition of Cpr6 to an Aha1-Hsp90-AMPPNP-Sba1 complex. simultaneously bound. This is consistent with the synergistic effects
Addition of Cpr6 (48.82M) to an Aha1-Hsp90-AMPPNP-Sba1 com- seen by these cochaperones in ATPase assays.
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Figure 7. The Effect of Cochaperones on the
ATPase Activity of Hsp90 and Its Complexes
Two micromolar of yeast Hsp90 and 1 M of
Aha1 or 20 M of Hsp90 and 20 M of Aha1
were used in assays.
(A) Inhibition of Hsp90 () and Aha1-Hsp90
() ATPase activities by cSti1. The relative
degree of inhibition for a given cSti concen-
tration is very similar.
(B) Activation of the Hsp90 ATPase activity
by () Cpr6 and () cCpr6. In the high-salt
buffer used previously, Cpr6 alone produced
no significant ATPase activation.
(C) Synergistic effects of Cpr6 and Aha1. Ad-
dition of Cpr6 (8 M) to Hsp90-Aha1 (2 and 1
M, respectively) elicits synergistic activation
of the ATPase. However, addition of Cpr6 to
Aha1-saturated Hsp90 (8 and 2 M, respec-
tively) has no further effect, indicating that
Hsp90 is fully activated by Aha1.
(D) Inhibition by Sba1 of the ATPase activity
of () Hsp90 and () Aha1-Hsp90 complex.
Substantial inhibition of ATPase activity is
achieved by moderate concentrations of
Sba1; however, further addition of Sba1 does
not significantly increase the degree of inhibi-
tion, and complete inhibition as observed
with Sti1 is not obtained at a 30 molar excess
of Sba1 over Hsp90.
(E) Inhibition of the ATPase activity of the
hHsp90-Aha1 complex by Cpr6, cSti1, and
Sba1. The synergistic effects of the cochap-
erones on the Aha1-stimulated ATPase activ-
ity of the human Hsp90 complex is the same
as that seen for the yeast Hsp90.
Sba1, which binds to the ATP-bound form of Hsp90, basal Hsp90 ATPase activity was observed with either
Cpr6 or its C-terminal TPR domain (cCpr6) (Figure 7B),also inhibits the inherent ATPase of Hsp90, but more
weakly. The KD for the interaction of Sba1 with AMPPNP- the peptidyl-prolyl isomerase domain (Mayr et al., 2000)
being entirely dispensable for this property. Addition ofbound Hsp90, estimated by CD spectroscopy, is 5
M (data not shown). This relatively low affinity explains saturating levels of Cpr6 to Hsp9050% saturated with
Aha1, nearly doubled the Aha1-stimulated ATPase activ-earlier observations of a lack of Hsp90 ATPase inhibition
by p23 (Young and Hartl, 2000), where the molar ratio ity. However, no superstimulation was observed when
Cpr6 was added to Hsp90 in the presence of saturatingof p23 (10 M) to Hsp90 (5 M) used would not have
been sufficiently high. Aha1 (Figure 7C). The activation afforded by the combi-
nation of Aha1 and Cpr6 was multiplicative rather thanAs Aha1 appears able to bind Hsp90 in the presence
of all cochaperones tested, we investigated the effect of additive, suggesting a synergistic interaction of these
proteins when bound to Hsp90, consistent with the addi-ATPase stimulation by Aha1 on the previously described
modulatory activities of these cochaperones. As with tional structural changes observed by CD when Cpr6 and
Aha1 are simultaneously present (Figures 6B and 6C).free Hsp90, the Aha1-stimulated ATPase activity of
Hsp90 was sensitive to Sti1/Hop (Figure 7A), suggesting Sba1 reduced the inherent ATPase activity of Hsp90
and the Aha1-Hsp90 complex (Figure 7D). The degreethat the mode of interaction and mechanism of inhibition
is the same, regardless of the presence of Aha1. In of inhibition elicited by Sba1 reached a plateau of50%
at around 1:1 stoichiometry (Sba1:Hsp90), but additionprevious studies, the TPR-domain immunophilin Cpr6
had no significant direct effect on the ATPase of free of further Sba1 up to 30 molar excess produced no
substantial extra decrease. This behavior is very differ-Hsp90 (Prodromou et al., 1999). However, with the
lower-salt buffer utilized here, an 2-fold increase in ent from Sti1 or Cdc37, which act early in the chaperone
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cycle and can completely inhibit the ATPase activity of was of primary importance, a further decrease in v-Src
activation in aha1-hch1 strains suggests that Hch1Hsp90. Instead, Sba1 acts after the rate-limiting step of
ATP binding and consequent dimerization (and possibly can replace Aha1 to a limited degree and implicates
both proteins in client protein activation by Hsp90. Ahydrolysis) and stabilizes the closed conformation of
Hsp90, slowing dissociation of the N-terminal domains formal demonstration that the ability of Aha1 (and to a
lesser extent Hch1) to stimulate the ATPase activity ofand ADP release. Finally, we showed that the effect of
the yeast cochaperones on the ATPase activity of the Hsp90 in vitro is critical to their involvement in CP activa-
tion in vivo will require isolation of Aha1 mutants ofhuman Hsp90-Aha1 complex was identical to that of
yeast Hsp90, suggesting that these regulatory pro- wild-type affinity for Hsp90 but with impaired ATPase
activation and may not be readily achieved. However,cesses are highly conserved from yeast to humans (Fig-
ure 7E). given the complementary involvement of Aha1 and Hch1
in Hsp90 function in vivo and the ability of Aha1, Hch1,
and the Hch1-homologous region of Aha1 to activateDiscussion
Hsp90’s ATPase activity in vitro, it seems most unlikely
that this common in vitro property of Hch1 and Aha1We have identified a family of related proteins, coregu-
does not reflect some aspect of their in vivo roles.lated in yeast and human cells with Hsp90 and its known
The different effects of individual cochaperones oncochaperones, and involved in stress-tolerance and
the ATPase activity of Hsp90 reflects the different con-Hsp90-CP activation in yeast. Together with the demon-
formational states of Hsp90 in its chaperone cycle andstration of direct interaction with Hsp90, these data
the specific association of individual cochaperones withclearly implicate Aha1 and Hch1 as cochaperones of
particular states and particular classes of client proteins.the Hsp90 system.
Compared to previously described cochaperones, Aha1Aha1 stimulates the inherent ATPase cycle of Hsp90,
is unusual in being able to coexist in complexes withwhich is essential for its chaperone activity in vivo (Pa-
early cochaperones such as Hop/Sti1 and p50/Cdc37,naretou et al., 1998; Obermann et al., 1998). Binding
and with late cochaperones such as Cyp40/Cpr6 andand hydrolysis of ATP in the Hsp90 chaperone cycle is
p23/Sba1. Aha1 may be a general upregulator of Hsp90directly coupled to changes in the conformational state
function, rather than a stage-specific cochaperone in-of the chaperone (Sullivan et al., 1997). Binding of ATP
volved in regulation of the lifetime of a particular confor-promotes a closed conformation in which the N-terminal
mation. As observed when other cochaperones are de-domains become physically associated, when then re-
leted (Chang et al., 1997; Dolinski et al., 1997; Duina etlaxes on ATP-hydrolysis to an open state in which the
al., 1996), yeast strains lacking Aha1 and/or Hch1 areN-terminal domains are unconstrained (Prodromou et
viable but are temperature and stress sensitive, andal., 2000; Chadli et al., 2000). Mutational studies indicate
impaired in their ability to activate clients such as v-Src.that ATP-hydrolysis by Hsp90 is a complex process in
Thus, the majority of Hsp90 cochaperones (includingwhich the association of the N-terminal domains in the
Aha1) are not essential for the basic operation of thedimer is rate limiting (Prodromou et al., 2000). As Aha1
Hsp90 system but may contribute to its efficiency anddoes not significantly alter the affinity of Hsp90 for ATP,
become particularly important in conditions of elevatedit does not act as a loading factor and must achieve
stress, where flux through the chaperone cycle my re-its activation by promoting the rate-limiting N-terminal
quire more stringent regulation. The identification of adimerization.
specific ATPase activator again emphasizes the key roleStimulation of ATPase activity by client proteins has
of the ATPase cycle in Hsp90 function, but how thisbeen observed in active chaperone systems such as
promotes activation of client proteins, is still to be deter-GroEL or Hsp70 (Jackson et al., 1993; Jordan and
mined.McMacken, 1995; McCarty et al., 1995; Yifrach and Hor-
ovitz, 1996). A similar effect is seen in nonchaperones
Experimental Proceduressuch as DNA gyrase B, to which Hsp90 is structurally
related (Prodromou et al., 1997), where ATPase activity
Strains and Plasmids
is stimulated by the addition of supercoiled DNA (Kam- The HSP83, AHA1, nAHA1 (residues 1–156), cAHA1 (residues 157–
pranis et al., 1999). Stimulation of human Hsp90 350), HCH1, cSTI1 (residues 237–589), CPR6, cCPR6 (residues 200–
ATPase activity by a fragment of the glucorticoid recep- 373), CPR7, cCPR7 (residues 202–393), SBA1, and the human
HSP90 genes were cloned into pRSETA as Nhe1-BamHI, Nhe-tor (GR) has also been observed (McLaughlin et al.,
EcoRI, or Nhe1-HindIII fragments and expressed as His6-tagged2002). However, the GR fragment used in the study was
fusions. The AHA1 and HCH1 cloned fragments possessed twoinherently dimeric unlike the true GR client that dimer-
nonnative amino acids (LeuGlu) represented by a XhoI at the 3	-OH
izes as a result of activation. This unnaturally dimerized end of the gene. Genes expressing Flag-tagged Hsp90 and Aha1
GR fragment may stimulate the ATPase by promoting (nonnative amino acids, LeuGlu, at its C terminus) were cloned as
a futile cycle in which Hsp90 is unable to change the NdeI-HindIII fragments in pRSETA. The yeast strain FY 1679-28C
(MATa ura3-52, his3  200, leu2  1, trp1  63) was used to generateconformation of the GR. However, the significance of
the hch (hch1  kanMX4), aha1 (aha1  hygB), and aha1-hch1these observations is unclear as the dimerized GR frag-
(hch1  kanMX4, aha1  hygB) strains.ment failed to stimulate the yeast Hsp90 to the same
degree, and its ability to bind ligand was not determined.
Tissue Culture and Stress Regulation of Human AHA1Direct evidence for the involvement of Aha1 and Hch1
Cells were grown, treated with 50 nM 17AAG or 0.6 M radicicol,
in the activation of v-Src was obtained by analyzing the harvested, and lysed as previously described (Hostein et al., 2001)
activation of v-Src immediately after induction, in strains except that antibiotics were omitted. For the heat shock experiment,
cells were incubated at 42C for 30 min, and then returned to 37Cin which Aha1, Hch1, or both were deleted. While Aha1
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for 24 hr. Samples (75 g protein) were separated on a 4%–20% Yeast Two-Hybrid Screening of Protein Interactions
Two-hybrid fusions utilizing the vectors pOAD and pOBD2 were con-SDS-PAGE gel and then transferred to nitrocellulose membrane.
Immunodetection was carried out with either primary antibody (Ab) structed according to published methods (http://depts.washington.
edu/sfields/yp_project/YPLM.html) (James et al., 1996; Uetz et al.,(rabbit polyclonal Aha1 1:5000 dilution, mouse monoclonal HSP70
SPA810 Stressgen 1:2000 dilution, or mouse monoclonal GAPDH 2000), and transformants were selected on medium lacking either
leucine, for the activator domain (AD) fusions, or tryptophan, for theChemicon 1:2000 dilution) followed by anti-mouse-IgG-HRP or anti-
rabbit-IgG-HRP at 1:1000 dilution (Amersham) and finally ECL binding domain (BD) fusions.
A centromeric vector expressing Hsp90-(BD) was constructed in(Pierce).
YCplac33 (Gietz and Sugino, 1988) by cloning the 1.3 kb HSP83
promoter (BamH1-Sal1), the ADH2 transcription terminator (Pst1-RNA Extraction and Microarray Analysis
Hind111) from pHSP83b (Panaretou et al., 1998), the HSP83 codingRNA extraction, labeling (0.5–1 g of Poly(A)
 mRNA), hybridization
region (Sal1-Pst1 and lacking the stop codon), and the GAL4 DNAconditions, phosphorimaging, and analysis have been previously
BD (Pst1 fragment) to yield pBDC90.described (Clarke et al., 2000). Signal intensity was normalized using
AD-ORF and BD-ORF (all except the HSP90-BD) fusions wereall data points and a reference mRNA sample comprising mRNA
inserted into the same strain by mating, and diploid cells were se-from untreated A2780 ovarian adenocarcinoma cells. Data were
lected on medium lacking leucine and tryptophan, which were thenorganized using self-organizing maps and analyzed as previously
screened for protein-protein interactions on the same medium ex-described (Eisen et al., 1998).
cept it was also lacking histidine and supplemented with increasing
concentrations (0–4 mM) of 3-amino-1,2,4-triazole. AD-ORF mating
Protein Extraction and Proteomics to the HSP90-BD fusion was selected on media lacking leucine and
A2780 cells were treated with 60 nM 17AAG (5 IC50) and harvested uracil and screened for protein-protein interactions on the same
after 8, 16, and 24 hr. Control A2780 cells treated with DMSO vehicle medium, except that it was also lacking histidine and supplemented
alone were harvested at 24 hr. Cell lysate preparations, 2D gel elec- with 0–4 mM 3AT. Colonies were scored after 10 days.
trophoresis, staining, image analysis (duplicate gels), and spot exci-
sion have been previously described (Harris et al., 2002). Protein
Coimmunoprecipitations
concentrations were 0.5–1 mg ml1. Gel spots were prepared and
Lysates prepared in buffer A (20 mM Tris [pH 7.5], protease inhibitors
subjected to in-gel digestion with modified trypsin similarly to meth-
[Roche], 0.1% Tween 20, 100 mM NaCl, and 5 mM MgCl2), containingods previously described (Clauser et al., 1995). MALDI mass spec-
about 10 g of flag-tagged Hsp90, was mixed with 50 g of His-
trometry was performed on a Reflex III MS in the reflector mode
tagged Aha1 and incubated for 30 min at 4C. Subsequently, 50 l
using delayed extraction. The peptide mass fingerprint recorded
of agarose-conjugated anti-Flag Ab (Sigma) was added, and the
was internally calibrated using the tryptic autolysis product ions at
lysate was incubated for 60 min at 4C. The agarose beads were
the monoisotopic masses of m/z 842.5100 and 2211.1046.
then washed twice at 4C with buffer A. Proteins retained by the
beads were then eluted with with 50 l SDS-loading buffer, and
AHA1 and hch1 Phenotype then 10l was loaded onto SDS-PAGE gels for blotting onto nitrocel-
The yeast strain FY 1679-28C and mutant strains (hch1, aha1, lulose filters. Blots were probed with anti-His6 mouse Ab (Clontech)
and aha1-hch1) were grown on YPD (2% glucose, 1% yeast followed by anti-mouse HRP-conjugated secondary Ab (Amersham).
extract, and 2% peptone) to midlog phase and diluted in YPD to Localization of the secondary Ab was with the ECL kit (Amersham).
1  104 cells ml1. One hundred microliter aliquots were inoculated
into a 96-well microtiter plate, and a temperature gradient was ap- Protein Expression, Purification, and ATPase Assays
plied (1C increment from left [30C] to right [39C] per well). After Proteins expressed as His6-tagged fusions were purified as de-
40 hr growth, cells were replicated to a YPDA plate (YPD 
 2% scribed previously using Talon metal-affinity chromatography,
agar) and incubated for 30 hr at 30C. The same yeast strains were Q-sepharose ion-exchange, and Superdex 75, 200, or sephacryl
also plated onto synthetic respiratory medium (YPEGA plates, 2% 400HR gel-filtration chromatography (Panaretou et al., 1998). Pro-
ethanol, 2% glycerol, 6.7%YNB without amino acids, and 2% agar teins were concentrated in 20 mM Tris (pH 7.5) containing 0–25 mM
supplemented with appropriate amino acids and nucleotides). Cells NaCl, 1 mM EDTA, and 0.5 mM DTT. The Hsp90 ATPase assay was
were grown at 30C for 6 days. performed as previously described (Panaretou et al., 1998), except
that the assay conditions were modified (45 mM Tris-Hcl [pH 7.5],
9 mM KCl, and 3 mM MgCl2), and for the nAha1 and Hch1 assaysPhenotype of vSrc Induction
20 mM Tris-Hcl (pH 7.5), 4 mM KCl, and 1.2 mM MgCl2 was used.Cells transformed with the centromeric ura3 vector, YpRS316v-Src
(Murphy et al., 1993; Nathan et al., 1999) expressing v-Src under
control of the Gal1 promoter were grown at 30C on repressive Circular Dichroism Spectroscopy
synthetic glucose (SG) medium (2% glucose, 0.67% YNB without CD spectra were recorded on a nitrogen-flushed JASCO J720 spec-
amino acids, 2% agar, and supplemented with appropriate amino tropolarimeter as previously described (Freeman et al., 1998; Pro-
acids and without uracil) or for induction of v-Src on synthetic galac- dromou et al., 1999; Siligardi and Hussain, 1998). The molar extinc-
tose (SGa) medium (2% galactose in place of glucose in SG). tion coefficients used were: (Hsp90)  54050 M1cm1, (Hch1)  20940
M1cm1, (Aha1)  50160 M1cm1, (cSti1)  34480 M1cm1, (Cpr6) 
18340 M1cm1, and (Sba1)  28650 M1cm1. A detailed descriptionActivation and Detection of v-Src-Activity and Protein Levels
of the theory and method of difference circular dichroism for investi-Cells transformed with YpRS316v-Src were grown at 30C to expo-
gating protein interactions is given in Siligardi et al. (2002).nential phase in synthetic raffinose (SR) medium (2% raffinose in
place of glucose in SG), harvested, and resuspended in 10 ml SR
Acknowledgmentswithout carbon source. Subsequently, 5 ml aliquots was transferred
into SR and SGa, incubated at 30C for 6 hr, harvested, and then
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